Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemanth Kumar

Showing results (331-340 of 350) with videos related to

Pageof 35
Sort By:
Cardiovascular Diabetology|May 7, 2017
Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female miceAnnayya R Aroor, Javad Habibi, Hemanth Kumar Kandikattu, et al.
Biomolecules|January 1, 2020
Biosynthesized ZnO-NPs from <i>Morus indica</i> Attenuates Methylglyoxal-Induced Protein Glycation and RBC Damage: In-Vitro, In-Vivo and Molecular Docking StudySatish Anandan, Murali Mahadevamurthy, Mohammad Azam Ansari, et al.
The Pediatric Infectious Disease Journal|January 31, 2016
Low Serum Concentrations of Rifampicin and Pyrazinamide Associated with Poor Treatment Outcomes in Children with Tuberculosis Related to HIV StatusGeetha Ramachandran, A K Hemanth Kumar, T Kannan, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2018
Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis TreatmentOmamah Alfarisi, Vidya Mave, Sanjay Gaikwad, et al.
Frontiers in Public Health|June 28, 2021
COVID-19 Pandemic-Frontline Experiences and Lessons Learned From a Tertiary Care Teaching Hospital at a Suburban Location of Southeastern IndiaV Nirmal Coumare, Swati Jayant Pawar, P S Manoharan, et al.
Emerging Infectious Diseases|November 21, 2018
Risk Factors for Acquiring Scrub Typhus among Children in Deoria and Gorakhpur Districts, Uttar Pradesh, India, 2017Jeromie Wesley Vivian Thangaraj, Ravi Vasanthapuram, Leonard Machado, et al.
Therapeutic Drug Monitoring|November 29, 2023
Effect of Metformin on Plasma Exposure of Rifampicin, Isoniazid, and Pyrazinamide in Patients on Treatment for Pulmonary TuberculosisAgibothu Kupparam Hemanth Kumar, Abhijit Kadam, Ramesh Karunaianantham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2022
Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant TuberculosisChandrasekaran Padmapriyadarsini, Vikram Vohra, Anuj Bhatnagar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
Randomized Trial of Metformin With Anti-Tuberculosis Drugs for Early Sputum Conversion in Adults With Pulmonary TuberculosisChandrasekaran Padmapriydarsini, Megha Mamulwar, Anant Mohan, et al.
Clinical Pharmacology and Therapeutics|November 20, 2023
A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in TuberculosisChandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar, et al.
Pageof 35

Showing results (331-340 of 350) with videos related to

Sort By:
Pageof 35
Cardiovascular Diabetology|May 7, 2017
Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female miceAnnayya R Aroor, Javad Habibi, Hemanth Kumar Kandikattu, et al.
Biomolecules|January 1, 2020
Biosynthesized ZnO-NPs from <i>Morus indica</i> Attenuates Methylglyoxal-Induced Protein Glycation and RBC Damage: In-Vitro, In-Vivo and Molecular Docking StudySatish Anandan, Murali Mahadevamurthy, Mohammad Azam Ansari, et al.
The Pediatric Infectious Disease Journal|January 31, 2016
Low Serum Concentrations of Rifampicin and Pyrazinamide Associated with Poor Treatment Outcomes in Children with Tuberculosis Related to HIV StatusGeetha Ramachandran, A K Hemanth Kumar, T Kannan, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2018
Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis TreatmentOmamah Alfarisi, Vidya Mave, Sanjay Gaikwad, et al.
Frontiers in Public Health|June 28, 2021
COVID-19 Pandemic-Frontline Experiences and Lessons Learned From a Tertiary Care Teaching Hospital at a Suburban Location of Southeastern IndiaV Nirmal Coumare, Swati Jayant Pawar, P S Manoharan, et al.
Emerging Infectious Diseases|November 21, 2018
Risk Factors for Acquiring Scrub Typhus among Children in Deoria and Gorakhpur Districts, Uttar Pradesh, India, 2017Jeromie Wesley Vivian Thangaraj, Ravi Vasanthapuram, Leonard Machado, et al.
Therapeutic Drug Monitoring|November 29, 2023
Effect of Metformin on Plasma Exposure of Rifampicin, Isoniazid, and Pyrazinamide in Patients on Treatment for Pulmonary TuberculosisAgibothu Kupparam Hemanth Kumar, Abhijit Kadam, Ramesh Karunaianantham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2022
Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant TuberculosisChandrasekaran Padmapriyadarsini, Vikram Vohra, Anuj Bhatnagar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2021
Randomized Trial of Metformin With Anti-Tuberculosis Drugs for Early Sputum Conversion in Adults With Pulmonary TuberculosisChandrasekaran Padmapriydarsini, Megha Mamulwar, Anant Mohan, et al.
Clinical Pharmacology and Therapeutics|November 20, 2023
A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in TuberculosisChandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar, et al.
Pageof 35